Colao Annamaria, Auriemma Renata S, Pivonello Rosario, Galdiero Mariano, Lombardi Gaetano
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, via S Pansini 5, 80131, Naples, Italy.
Rev Endocr Metab Disord. 2008 Mar;9(1):21-31. doi: 10.1007/s11154-007-9062-0.
This chapter discusses the effects of biochemical control of acromegaly on cardiovascular diseases, metabolic complications, respiratory abnormalities, malignancies and bone alterations. Acromegaly is associated with increased morbidity and mortality for cardiovascular and respiratory complications, whereas neoplasms seem to be a minor cause of increased risk of death. Other associated diseases are osteoarthritis, carpal tunnel syndrome, fatigue, visual abnormalities and reproductive disorders. Acromegaly results in premature death because of prolonged elevation of GH an IGF-I levels, and a strong biochemical control improves well-being and restores life expectancy to normal. The main goals of medical treatment of acromegaly include normalization of biochemical markers of disease activity, improvement in signs and symptoms of the disease, removal or reduction of tumor mass and preservation of pituitary function.
本章讨论肢端肥大症的生化控制对心血管疾病、代谢并发症、呼吸异常、恶性肿瘤和骨骼改变的影响。肢端肥大症与心血管和呼吸并发症的发病率和死亡率增加相关,而肿瘤似乎是死亡风险增加的次要原因。其他相关疾病包括骨关节炎、腕管综合征、疲劳、视觉异常和生殖障碍。由于生长激素(GH)和胰岛素样生长因子-Ⅰ(IGF-Ⅰ)水平长期升高,肢端肥大症会导致过早死亡,而强有力的生化控制可改善健康状况并使预期寿命恢复正常。肢端肥大症医学治疗的主要目标包括使疾病活动的生化标志物正常化、改善疾病的体征和症状、去除或缩小肿瘤体积以及保留垂体功能。